Wednesday, July 2, 2025 7/2/2025

Structural and Functional Characterization of METTL13

Award Number: F31GM145170
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 08/11/2022
PERIOD OF PERFORMANCE END DATE: 08/10/2023

Group Awards By:

View Award Description

Structural and Functional Characterization of METTL13 - PROJECT SUMMARY Advances in research on protein α-N-terminal (Nα) methylation have brought to light the important role of this post-translational modification in the regulation of mitosis, chromatin interactions, and DNA repair. Altered methylation levels result in the aberrant expression of N-terminal methyltransferases (NTMTs); this aberrant expression is often implicated in the development of various diseases. However, the function of N-terminal methylation and its role in disease pathogenesis remains poorly characterized. Until recently, N-terminal methylation was believed to only occur on a conserved X-P-K motif of protein substrates and catalyzed by only two enzymes, NTMT1 and NTMT2. Identification of N-terminal methylation on the eukaryotic elongation factor 1 alpha (eEF1A) GKEK motif, a non-canonical NTMT motif, has challenged this paradigm, bringing to light the possibility for additional existing NTMT substrates. The methyltransferase like 13 (METTL13) enzyme has very recently been identified as the methyltransferase responsible for eEF1A N-terminal methylation. METTL13 is a dual methyltransferase that can methylate both the N-terminus of Lys55 of eEF1A through its separate methyltransferase domains, but the biological roles of these methylations are currently unclear. The implication of both METTL13 and eEF1A in the poor prognosis associated with pancreatic, lung, and bladder cancers motivates us to interrogate the role of this novel methylation event in cellular dysfunction. The downstream effects of dysfunctional METTL13 substrate recognition and catalysis and their relation to cancer development are entirely unknown, which highlights a critical need to identify the structural and mechanistic details of METTL13- mediated Nα methylation that govern cancer pathogenesis and progression. My central hypothesis is that METTL13-mediated eEF1A Nα methylation may serve a distinct functional role from eEF1A Lys55 methylation and their dysregulation may yield different biological outcomes in a tissue-specific manner. The long-term goals of this proposal are to (1) generate a comprehensive understanding of the substrate recognition, regulation, and function of Nα methylation catalyzed by METTL13 and (2) determine the relation between METTL13-mediated Nα methylation and cancer progression. The results from this research will clarify the biological role of Nα methylation and define structural features of METTL13 that have the potential to inform future targeted cancer therapies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = -$1,886 )
2024	2022	PURDUE UNIVERSITY	2550 NORTHWESTERN AVE # 1100	WEST LAFAYETTE	IN	47906	TIPPECANOE	USA	Biomedical Research and Research Training	000	1	6/24/2024	NEW	-$1,886
														Subtotal = -$1,886

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2022	PURDUE UNIVERSITY	2550 NORTHWESTERN AVE STE 1900	WEST LAFAYETTE	IN	47906	TIPPECANOE	USA	Biomedical Research and Research Training	000	1	8/14/2023	NEW	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $46,752 )
2022	2022	PURDUE UNIVERSITY	2550 NORTHWESTERN AVE STE 1900	WEST LAFAYETTE	IN	47906	TIPPECANOE	USA	Biomedical Research and Research Training	001	1	7/27/2022	NEW	$0
2022	2022	PURDUE UNIVERSITY	2550 NORTHWESTERN AVE STE 1900	WEST LAFAYETTE	IN	47906	TIPPECANOE	USA	Biomedical Research and Research Training	000	1	7/27/2022	NEW	$46,752
														Subtotal = $46,752

Grand Total All Awards = $44,866

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Structural and Functional Characterization of METTL13

Award Number: F31GM145170

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 08/11/2022

PERIOD OF PERFORMANCE END DATE: 08/10/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer